Senior insider sale
Chief Financial Officer at ALPHA TAU MEDICAL LTD. — senior position signals high conviction
$1.24M
102.50K shares
LEVY RAPHI plans to sell 102.50K shares of ALPHA TAU MEDICAL LTD. valued at approximately $1.24M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Shares acquired upon exercise of employee stock options
Cash payment upon exercise of stock options
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2026 | Shares acquired upon exercise of employee stock options Cash payment upon exercise of stock options | 5K | — |
| Total | 5K | ||
Completed
Units to sell
17.73K
Market value
$248.3K
Units to sell
2.27K
Market value
$31.8K
Units to sell
17.87K
Market value
$232.4K
Units to sell
2.13K
Market value
$27.7K
Units to sell
20K
Market value
$240.0K
Units to sell
20K
Market value
$220.0K
Units to sell
17.50K
Market value
$167.1K
Planned — Approximate Date
Units to sell
5K
Market value
$71.8K
Units
102.50K
Value
$1.24M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/11/2026 | 17.73K | $248.3K | — | Completed |
7/6/2026 | 2.27K | $31.8K | — | Completed |
7/2/2026 | 17.87K | $232.4K | — | Completed |
7/1/2026 | 2.13K | $27.7K | — | Completed |
6/30/2026 | 20K | $240.0K | — | Completed |
6/25/2026 | 20K | $220.0K | — | Completed |
6/23/2026 | 17.50K | $167.1K | — | Completed |
| Planned — Approximate Date | ||||
8/21/2026 | 5K | $71.8K | Nasdaq | Planned |
| Total | 102.50K | $1.24M | ||